Assessment of Organ-at-risk Sparing in Esophageal Cancer: A Comparative Dosimetric Evaluation of Hybrid, Noncoplanar, and Coplanar RapidArc Plans.

IF 0.7 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Journal of Medical Physics Pub Date : 2024-07-01 Epub Date: 2024-09-21 DOI:10.4103/jmp.jmp_63_24
Mukesh Kumar Zope, Deepali Bhaskar Patil, Dinesh Kumar Saroj
{"title":"Assessment of Organ-at-risk Sparing in Esophageal Cancer: A Comparative Dosimetric Evaluation of Hybrid, Noncoplanar, and Coplanar RapidArc Plans.","authors":"Mukesh Kumar Zope, Deepali Bhaskar Patil, Dinesh Kumar Saroj","doi":"10.4103/jmp.jmp_63_24","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>The purpose of this study is to improve the precision of radiation treatment and sparing of organ-at-risk (OAR) in patients with thoracic esophageal cancer (EC) affecting the heart, lung, and spinal cord. To improve and personalize cancer treatment plans, it assesses the dosimetric benefits of coplanar RapidArc (RA<sub>c</sub>), hybrid arc (RA<sub>Hyb</sub>), and noncoplanar RapidArc (RA<sub>nc</sub>).</p><p><strong>Materials and methods: </strong>Fourteen patients with EC were chosen for our investigation from our hospital's database. RapidArc (RA) plan patients had already received treatment. Retrospectively, additional RA<sub>nc</sub> and RA<sub>Hyb</sub> plans were made with a prescription dose of 50.4 Gy in 28 fractions for the planning target volume (PTV). A prescription dose of 95% of PTV was used, so that three different treatment planning procedures could be compared. The cumulative dose-volume histogram was used to analyze the plan quality indices homogeneity index (HI), conformity index (CI), conformation number (CN) as well as the OARs doses to the lung, heart, and spinal cord.</p><p><strong>Results: </strong>In comparison to RA<sub>c</sub> and RA<sub>nc</sub> techniques, the study indicated that RA<sub>Hyb</sub> plans significantly increased D95%, CI and HI; Dmax and CN did not differ substantially. In addition, compared to RA<sub>c</sub> (lung: 16.15 ± 0.03 Gy and heart: 23.91 ± 4.67 Gy) and RA<sub>nc</sub> (lung: 15.24 ± 0.03 Gy and heart 23.82 ± 5.10 Gy) plans, RA<sub>Hyb</sub> resulted in significantly lower mean lung doses (15.10 ± 0.03 Gy) and heart doses (21.33 ± 6.99 Gy). Moreover, the RA<sub>Hyb</sub> strategy showed a statistically significant (<i>P</i> < 0.05) lower average MU (452.7) than both the RA<sub>c</sub> (517.5) and RA<sub>nc</sub> (566.2) plans.</p><p><strong>Conclusion: </strong>The D95%, conformity, and homogeneity indices were better for hybrid arc plans compared to RA<sub>c</sub> and RA<sub>nc</sub> plans. They also successfully managed to reduce the lung and heart doses as well as the mean MU per fraction.</p>","PeriodicalId":51719,"journal":{"name":"Journal of Medical Physics","volume":"49 3","pages":"419-426"},"PeriodicalIF":0.7000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11548063/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Physics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jmp.jmp_63_24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/21 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: The purpose of this study is to improve the precision of radiation treatment and sparing of organ-at-risk (OAR) in patients with thoracic esophageal cancer (EC) affecting the heart, lung, and spinal cord. To improve and personalize cancer treatment plans, it assesses the dosimetric benefits of coplanar RapidArc (RAc), hybrid arc (RAHyb), and noncoplanar RapidArc (RAnc).

Materials and methods: Fourteen patients with EC were chosen for our investigation from our hospital's database. RapidArc (RA) plan patients had already received treatment. Retrospectively, additional RAnc and RAHyb plans were made with a prescription dose of 50.4 Gy in 28 fractions for the planning target volume (PTV). A prescription dose of 95% of PTV was used, so that three different treatment planning procedures could be compared. The cumulative dose-volume histogram was used to analyze the plan quality indices homogeneity index (HI), conformity index (CI), conformation number (CN) as well as the OARs doses to the lung, heart, and spinal cord.

Results: In comparison to RAc and RAnc techniques, the study indicated that RAHyb plans significantly increased D95%, CI and HI; Dmax and CN did not differ substantially. In addition, compared to RAc (lung: 16.15 ± 0.03 Gy and heart: 23.91 ± 4.67 Gy) and RAnc (lung: 15.24 ± 0.03 Gy and heart 23.82 ± 5.10 Gy) plans, RAHyb resulted in significantly lower mean lung doses (15.10 ± 0.03 Gy) and heart doses (21.33 ± 6.99 Gy). Moreover, the RAHyb strategy showed a statistically significant (P < 0.05) lower average MU (452.7) than both the RAc (517.5) and RAnc (566.2) plans.

Conclusion: The D95%, conformity, and homogeneity indices were better for hybrid arc plans compared to RAc and RAnc plans. They also successfully managed to reduce the lung and heart doses as well as the mean MU per fraction.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
食管癌风险器官疏通评估:混合、非共面和共面 RapidArc 计划的剂量学比较评估
目的:本研究旨在提高胸腔食管癌(EC)患者放射治疗的精确度,并保护影响心脏、肺部和脊髓的高危器官(OAR)。为了改进和个性化癌症治疗计划,该研究评估了共面快速弧(RAc)、混合弧(RAHyb)和非共面快速弧(RAnc)的剂量学优势:我们从医院的数据库中选取了 14 名心血管疾病患者进行调查。快速弧(RA)计划患者已经接受了治疗。回顾性地制定了额外的 RAnc 和 RAHyb 计划,计划靶体积(PTV)的处方剂量为 50.4 Gy,分 28 次进行。使用的处方剂量为 PTV 的 95%,以便对三种不同的治疗计划程序进行比较。累积剂量-体积直方图用于分析计划质量指标均匀性指数(HI)、符合性指数(CI)、构象数(CN)以及肺、心脏和脊髓的OARs剂量:结果:与 RAc 和 RAnc 技术相比,研究表明 RAHyb 方案显著提高了 D95%、CI 和 HI;Dmax 和 CN 没有显著差异。此外,与 RAc(肺部:16.15 ± 0.03 Gy,心脏:23.91 ± 4.67 Gy)和 RAnc(肺部:15.24 ± 0.03 Gy,心脏 23.82 ± 5.10 Gy)计划相比,RAHyb 使肺部平均剂量(15.10 ± 0.03 Gy)和心脏剂量(21.33 ± 6.99 Gy)明显降低。此外,与 RAc(517.5)和 RAnc(566.2)方案相比,RAHyb 方案的平均 MU(452.7)在统计学上有显著差异(P < 0.05):结论:与RAc和RAnc计划相比,混合弧计划的D95%、一致性和均匀性指数更好。结论:与 RAc 和 RAnc 计划相比,混合弧计划的 D95%、保形性和均匀性指数都更好,而且还成功地降低了肺和心脏剂量以及每分数的平均 MU。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Medical Physics
Journal of Medical Physics RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-
CiteScore
1.10
自引率
11.10%
发文量
55
审稿时长
30 weeks
期刊介绍: JOURNAL OF MEDICAL PHYSICS is the official journal of Association of Medical Physicists of India (AMPI). The association has been bringing out a quarterly publication since 1976. Till the end of 1993, it was known as Medical Physics Bulletin, which then became Journal of Medical Physics. The main objective of the Journal is to serve as a vehicle of communication to highlight all aspects of the practice of medical radiation physics. The areas covered include all aspects of the application of radiation physics to biological sciences, radiotherapy, radiodiagnosis, nuclear medicine, dosimetry and radiation protection. Papers / manuscripts dealing with the aspects of physics related to cancer therapy / radiobiology also fall within the scope of the journal.
期刊最新文献
A Segmentation-based Automated Calculation of Patient Size and Size-specific Dose Estimates in Pediatric Computed Tomography Scans. A Study on Radiation Level at the Treatment Plane Due to Induced Activity in Linear Accelerator Head. Advancements and Applications of Three-dimensional Printing Technology in Surgery. Agar-based Phantom for Evaluating Targeting of High-intensity Focused Ultrasound Systems for Breast Ablation. An Analysis of Radiotherapy Machine Requirements in India: Impact of the Pandemic and Regional Disparities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1